Health system needs new ideas and leadership, says minister.

New Zealand isn't prepared enough for the next big pandemic, public health experts argue.

Three investigations so far into Dr Nigel Murray's spending, a further two possible.

An obstetrician has been criticised over the death of a baby in her care.

Editorial: Ronald McDonald Houses are being rejected by DHB officials, not boards.

For the first time Simcock has admitted a process error over Murray debacle.

A total of 542 adverse events were reported by district health boards in the last year.

Reasons for resignation of Brett Paradine unclear.

About 30 per cent of high-school pupils may not be fully immunised against mumps.

HealthTap is not the first American IT system bought into by Waikato DHB.

The SmartHealth app is here to stay but which provider powers it is under review.

Ideas are being touted of how to end the worst mumps outbreak in years.

Southern CEO blames doctors for failing to meet targets and promising too many operations.

Opposition says Government playing politics with demand health board chairmen resign.

OPINION: If the Ronald McDonald charity can't help at hospital, someone else needs to.

Staff at Hillmorton Hospital have been bitten, hit and injured while restraining patients.

Mental health will be a key focus of the new government

Ebos takes 14% stake in Australian medi-software firm MedAdvisor for A$10.5m.

A baby has suffered irreparable brain damage because of a rare reaction to anaesthetic.

Claire Trevett lifts the lid on the plan - and the man - to breathe life into the party.

Experts believe taking the pills helps reduce inflammation and wards off viruses.

'Transplant twins' Keith Eades and Diane Plimmer aren't taking anything for granted.

Many general practices, crucial for schooling junior doctors, are at training capacity.

Midwife told to delete post about 'hidden shame' of incest and poverty in South Auckland.

A second hospital is dealing with highly contagious vomiting bug.

Parties' expected surpluses much the same - but health is a key difference.

Breast cancer drug Ibrance is now available in New Zealand but at an eye-watering cost

Abano Healthcare completes $35 million capital raising, including shortfall.

Fisher & Paykel Healthcare lowered full year earnings guidance due to the strong NZ dollar

Abano's dissident shareholders to exit in discounted block trade